Magnesium L-Threonate.

The liver and kidney enzymes that convert vitamin D into its active form each rely on magnesium as a cofactor, so adequate magnesium supports the body's normal activation of the vitamin D it makes or absorbs. When magnesium is low, that conversion step runs less efficiently.

Calcium and magnesium act as counterparts in normal nerve and muscle signaling, with calcium driving contraction and magnesium supporting the relaxation phase by moderating calcium's entry into cells. Because both are taken up as divalent minerals, a large dose of one at the same time can modestly lower absorption of the other.

Magnesium is required by the sodium and potassium pump (Na,K-ATPase) that keeps potassium concentrated inside cells, so adequate magnesium helps the body hold potassium and maintain its normal balance. When magnesium is low, cells give up potassium more readily and it is harder to restore with potassium alone.

Vitamin B6 is thought to help magnesium move into and stay within cells, which is the long-standing rationale for combining the two in a single formula. The cellular mechanism is not fully settled, so the pairing rests on established formulation practice more than on firm biochemistry.

Magnesium-dependent enzymes carry out the two hydroxylation steps that activate vitamin D, and vitamin K2 carboxylates the matrix proteins that place calcium into bone. The three are formulated together so calcium handling stays orderly.

Thiamine works as thiamine pyrophosphate, and the enzymes that use it also need magnesium bound at the active site. Magnesium status therefore sets how well thiamine-dependent energy steps run even when thiamine intake is adequate.

ATP is biologically active as a magnesium-ATP complex, and creatine works by handing a phosphate back onto ADP. Magnesium is part of the same phosphate-transfer step creatine feeds.

Glycine acts on its own inhibitory receptors in the central nervous system, and it is also the amino acid used to chelate magnesium in common absorbable forms. That double role is why the two appear together in evening formulas.

Boron influences renal handling of magnesium and calcium, so adequate boron is associated with lower urinary magnesium loss. It is used at trace amounts alongside the mineral rather than as a substitute for it.

Zinc and magnesium share divalent cation transport routes in the intestine, and large single doses of one can reduce uptake of the other taken at the same time. At ordinary supplemental amounts the effect is small. Spacing the two is the usual formulation response where doses are high.

Non-heme iron and magnesium both rely on divalent cation uptake at the brush border, so a large iron dose and a large magnesium dose taken together compete. The interaction is dose dependent and largely disappears when the two are taken hours apart. It is a competition for uptake, not a claim about either mineral's function.

Magnesium and phosphate form poorly soluble magnesium phosphate salts in the gut lumen, which reduces the amount of either available for absorption. Phosphate-heavy foods and phosphate supplements taken with magnesium have this effect. Straight solubility chemistry.

Calcium carbonate raises gastric pH, and mineral salts dissolve less readily as the stomach becomes less acidic. Taken together with a magnesium salt it can lower how much magnesium goes into solution before it reaches the absorptive surface. The magnitude depends on dose and on whether the two are taken with food.

Manganese shares divalent transporters with magnesium and other minerals in the same family. Competition is documented for the transporter, though supplemental manganese doses are small enough that practical effects are unlikely. Worth listing so a multi-mineral formula's mineral load is understood as a whole.

Copper uptake overlaps with the divalent transport machinery that also carries magnesium, so a very large mineral load can interfere. The overlap is documented at the transporter level rather than in supplement-dose trials. Listed for completeness in multi-mineral formulation.

Riboflavin kinase, the enzyme that converts riboflavin to FMN, requires magnesium and ATP, and the following step to FAD is likewise magnesium dependent. Without adequate magnesium, riboflavin is not efficiently converted to its active cofactor forms. Textbook enzymology.

NAD kinase and the salvage-pathway enzymes that build NAD all use ATP, which is biologically active only as the magnesium complex. Magnesium status therefore sits underneath NAD handling rather than beside it. This is a cofactor relationship, not a combination effect.

Nicotinamide mononucleotide adenylyltransferase converts NMN to NAD using ATP, and every ATP-using enzyme works on Mg-ATP rather than free ATP. Magnesium is a silent requirement in that conversion. Settled biochemistry with no combination trial behind it.

L-threonate is a downstream oxidation product of ascorbic acid, which is where the anion in this salt comes from. That makes the counter-ion a vitamin C metabolite rather than an inert carrier, and it is the reason this salt is chemically distinct from inorganic magnesium salts. The relationship is compositional, and it is not a claim that the salt delivers vitamin C activity.

Melatonin acts on circadian receptor signalling while magnesium acts on NMDA receptor gating and GABA-A modulation, so the two arrive at sleep-related endpoints by different routes. Formulas commonly carry both. Anyone stacking several sedating ingredients should count them together rather than separately.

Theanine influences glutamate and GABA signalling and raises alpha-wave activity on EEG, which is the same neurotransmitter territory magnesium acts in through NMDA receptor block. The two are frequently combined in evening formulas. Combination data is thin and the endpoints are mostly self-reported.

Taurine is a glycine and GABA-A receptor modulator and also affects intracellular calcium handling, an area magnesium is central to. Formulators pair them for that overlap. The pairing rests on mechanism rather than on measured combination outcomes.

Caffeine has a mild diuretic effect that increases urine flow and with it urinary magnesium loss. Habitual high intake is therefore one input into magnesium balance. The effect on balance is modest and adapts with regular use.

A high sodium load increases urinary excretion of divalent cations including magnesium, because sodium handling in the loop of Henle drives the electrical gradient that magnesium reabsorption depends on. This is renal physiology, measured in balance studies. It is an input into status rather than an interaction at the point of dosing.

Fermentable fructans lower colonic pH and increase the surface available for passive mineral uptake, and human work on calcium and magnesium absorption has used this route. Colonic absorption is a real secondary route for magnesium. The work is on inorganic magnesium salts, not on this salt specifically.

Short-chain fructooligosaccharides ferment in the proximal colon and produce short-chain fatty acids that acidify the lumen and keep magnesium soluble. Absorption studies in the fructan literature report increased mineral uptake on this route. Measured for magnesium as a mineral, not for the threonate salt.

Phytic acid in whole grains and legumes binds magnesium in the gut and carries it through unabsorbed. Phytase cleaves phosphate groups off the phytate ring and releases the bound mineral. The chemistry is established in food science; supplemental phytase in a human meal setting is less studied.

Mineral salts dissolve better in an acid environment, and betaine hydrochloride lowers gastric pH transiently. That would be expected to help less soluble magnesium salts more than well soluble ones. Magnesium L-threonate is already water soluble, so any benefit here is likely small.